2010
DOI: 10.1016/j.neulet.2010.07.050
|View full text |Cite
|
Sign up to set email alerts
|

Antagonism of orexin type 1 receptors in the locus coeruleus attenuates signs of naloxone-precipitated morphine withdrawal in rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
18
1

Year Published

2012
2012
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 46 publications
(21 citation statements)
references
References 41 publications
2
18
1
Order By: Relevance
“…Our results indicate that the blockade of OX1R significantly decreased several of the somatic signs of naloxone-precipitated morphine withdrawal as well as the global score, suggesting that activation of OX1R pathways might positively modulate the somatic expression of opiate withdrawal. These data are in agreement with previous results showing that administration of SB334867 directly into LC to rats attenuates signs of morphine withdrawal [16]. In addition, mice lacking the pre-propeptide encoding for orexins or pretreated with SB334867 display markedly reduced symptoms of opiate withdrawal [14], [15].…”
Section: Discussionsupporting
confidence: 93%
“…Our results indicate that the blockade of OX1R significantly decreased several of the somatic signs of naloxone-precipitated morphine withdrawal as well as the global score, suggesting that activation of OX1R pathways might positively modulate the somatic expression of opiate withdrawal. These data are in agreement with previous results showing that administration of SB334867 directly into LC to rats attenuates signs of morphine withdrawal [16]. In addition, mice lacking the pre-propeptide encoding for orexins or pretreated with SB334867 display markedly reduced symptoms of opiate withdrawal [14], [15].…”
Section: Discussionsupporting
confidence: 93%
“…One possible explanation of a lack of SB334867effect may be that the doses used were not behaviorally relevant. This interpretation is unlikely, however, because it has been shown by others that SB334867 at doses even lower than the ones tested in the present study attenuated physical symptoms of morphine withdrawal as well as cocaine seeking-behavior when injected in the locus coeruleus and in the ventral tegmental area, respectively (Azizi et al, 2010;James et al, 2011). Another more acceptable hypothesis is that the effect of a peripheral administration (i.e., not site specific) of SB334867 may be attributable to its action in brain regions other than the PVT.…”
Section: Discussioncontrasting
confidence: 60%
“…A prior study showed an involvement of orexin receptors in LC in somatic signs of opiate withdrawal (Azizi et al, 2010). However, in our study LH orexin neurons that project to LC were not significantly Fos-activated after preference testing.…”
Section: Discussionmentioning
confidence: 99%